[1]崔爱惠,张新安,路 越.中医传统功法联合培土化毒方在SOX方案治疗 晚期结直肠癌中的临床疗效[J].医学信息,2019,(17):5-8.[doi:10.3969/j.issn.1006-1959.2019.17.002]
 CUI Ai-hui,ZHANG Xin-an,LU Yue.Clinical Efficacy of Traditional Chinese Medicine Combined with Peihuahuadu Recipe in the Treatment of Advanced Colorectal Cancer with SOX Regimen[J].Medical Information,2019,(17):5-8.[doi:10.3969/j.issn.1006-1959.2019.17.002]
点击复制

中医传统功法联合培土化毒方在SOX方案治疗 晚期结直肠癌中的临床疗效()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期数:
2019年17期
页码:
5-8
栏目:
直肠癌专题
出版日期:
2019-09-01

文章信息/Info

Title:
Clinical Efficacy of Traditional Chinese Medicine Combined with Peihuahuadu Recipe in the Treatment of Advanced Colorectal Cancer with SOX Regimen
文章编号:
1006-1959(2019)17-0005-04
作者:
崔爱惠12张新安1路 越3
1.沈阳体育学院运动人体科学学院,辽宁 沈阳 110102; 2.辽宁医药职业学院,辽宁 沈阳 110101; 3.辽宁中医药大学附属第三医院,辽宁 沈阳 110003
Author(s):
CUI Ai-hui12ZHANG Xin-an1LU Yue3
1.School of Sports Human Science,Shenyang Sport University,Shenyang 110102,Liaoning,China; 2. Liaoning Vocational College of Medicine,Shenyang 110101,Liaoning,China; 3.the Third Affiliated Hospital of Liaoning University of Traditional Chinese Medicine,Shenyang 110003,Liaoning,China
关键词:
传统功法培土化毒方SOX方案结直肠癌
Keywords:
Key words:Traditional exercisesPeifanghuadufangSOX regimenColorectal cancer
分类号:
R735.3+4
DOI:
10.3969/j.issn.1006-1959.2019.17.002
文献标志码:
A
摘要:
目的 观察中医传统功法联合培土化毒方及SOX方案治疗结直肠癌的疗效及安全性。方法 将2018年1月~12月在辽宁中医药大学附属三院就诊诊断为晚期结直肠癌的患者80例,随机分为对照组与治疗组,每组40例。对照组予SOX方案,治疗组在此基础上采用中药处方联合中医传统功法治疗。比较两组肿瘤病灶进行评价、中医症状评分、体力状况评分、观察近期疗效及安全性指标。结果 治疗组有效率为35.00%,临床获益率82.50%,分别高于对照组的32.50%、80.00%,差异无统计学意义(P>0.05)。治疗组总有效率为65.00%,高于对照组的42.50%,治疗组治疗前后中医症状积分比较,统计学意义均显著(P<0.01);对照组治疗前后比较,差异无统计学意义(P>0.05);治疗后治疗组中医症状积分低于对照组,统计学意义显著(P<0.01);治疗后治疗组KPS评分高于对照组,统计学意义显著(P<0.01);两组治疗期间无死亡病例,主要的不良反应为骨髓抑制、消化道反应以及末梢神经炎等。两组白细胞减少分度比较,统计学意义显著(P<0.01);在恶心呕吐分度比较,差异有统计学意义(P<0.05);治疗组其它毒性反应发生率均较对照组低,但差异均无统计学意义(P>0.05)。结论 中医传统功法联合培土化毒方及SOX方案治疗结直肠癌能改善患者症状,减轻化疗不良反应,提高生活质量。
Abstract:
Abstract:Objective To observe the efficacy and safety of traditional Chinese medicine combined with Peifang Huadu Decoction and SOX regimen in the treatment of colorectal cancer.Methods 80 patients with advanced colorectal cancer who were diagnosed in the Third Affiliated Hospital of Liaoning University of Traditional Chinese Medicine from January to December 2018 were randomly divided into control group and treatment group, with 40 cases in each group. The control group was given the SOX regimen, and the treatment group was treated with traditional Chinese medicine prescription combined with traditional Chinese medicine. The tumor lesions of the two groups were compared, TCM symptom scores, physical status scores, and short-term efficacy and safety indicators were observed.Results The effective rate of the treatment group was 35.00%, and the clinical benefit rate was 82.50%, which was higher than 32.50% and 80.00% of the control group, respectively,the difference was not statistically significant (P>0.05). The total effective rate of the treatment group was 65.00%, which was higher than that of the control group 42.50%. The scores of TCM symptom scores before and after treatment in the treatment group were statistically significant (P<0.01).There was no significant difference between the control group and the control group(P>0.05); The score of TCM symptom in the treatment group was lower than that in the control group after treatment, the statistical significance was significant (P<0.01); the KPS score of the treatment group was higher than that of the control group after treatment, the statistical significance was significant (P<0.01); There were no deaths during the treatment period. The main adverse reactions were myelosuppression, digestive tract reaction and peripheral neuritis. The difference of leukopenia between the two groups was statistically significant (P<0.01). The difference in nausea and vomiting was statistically significant (P<0.05). The incidence of other toxic reactions in the treatment group was lower than that in the control group, but the difference was not statistically significant (P>0.05).Conclusion Traditional Chinese medicine combined with Peihua Huadu Decoction and SOX regimen can improve the symptoms of patients with colorectal cancer, reduce the adverse reactions of chemotherapy and improve the quality of life.

参考文献/References:

[1]张凯,刘培培,张伟杰,等.替吉奥胶囊联合奥沙利铂方案加贝伐单抗治疗晚期结直肠癌的临床观察[J].肿瘤防治研究,2014,41(9):1036-1039. [2]郑博丹,吴都督,王功顺.天然中药配合物的抗肿瘤活性及其机制研究[J].医学综述,2019,25(6):1233-1236,1240. [3]中华人民共和国卫生和计划生育委员会医政医管局,中华医学会肿瘤学分会.中国结直肠癌诊疗规范(2017年版)[J].中华外科杂志,2018,56(4):241-258. [4]葛青云,陈玉根.基于现代文献分析大肠癌中医证型及症状、体征分布规律[J].吉林中医药,2018,38(6):625-628. [5]Duffaud F,Therasse P.New guidelines to evaluate the response to treatment in solid tumors[J]. Bulletin Cancer,2000,87(12):881-886. [6]李永亮,刑珊珊,罗以,等.替加氟或氟尿嘧啶联合奥沙利铂对结直肠癌术后辅助化疗的疗效比较[J].世界华人消化杂志,2013,21(31):3460-3463. [7]桂东.SOX方案与XELOX方案治疗胃癌新辅助化疗的对比[J].四川医学,2019,40(1):71-74. [8]代金刚,曹洪欣,张明亮.《诸病源候论》呼吸吐纳法浅探[J].中医杂志,2016,57(3):267-270.

更新日期/Last Update: 2019-09-01